HOT🔥: thermography of hands in IA remotely collected via smartphone correlates w/ US features 0.48, p<0.01 and SJC 0.48, p<0.01), DAS28 (0.73, p<0.01), CDAI (0.84, p<0.01) and SDAI (0.82, p<0.01). A future tool for patients remote follow-up? #OP0300 @Rheumnow #EULAR2021 https://t.co/MJLpz6eqIy

Just a reminder: RA-ILD doesn't just happen in early disease; risk continues on long after diagnosis. PS don't smoke if you have RA; smokers have an adj HR 1.92 PPS don't smoke if you don't want to get RA PPPS don't smoke. @MayoClinic POS0210 #EULAR2021 @RheumNow https://t.co/elhvJrK7B4

Presenting now at #EULAR2021 #COVID19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with #rituximab: a cohort study https://t.co/QTGkiMcC2d https://t.co/DJB6GooPuJ

• DEFINE_ME

#EULAR2021. OP0293: Best disease activity measure for SLE flares? ⭐️c-SFI and SLE-DAS had best performance ⭐️SLE-DAS: easy to use for daily practice @RheumNow https://t.co/9LJfbYxqOs

Which RA pts have high HAQ? F/U of 2 ERA cohorts [NOAR 1001 pts, #ESPOIR 767 pts] compared pts with high vs lower HAQ. DAS28 was = in 2 groups! But high HAQ occurred in older, females &⬆️fatigue OP0183 #EULAR2021 @RheumNow @eular_org

Is #JAKi better on PROs than #Adalimumab in MTX-IR pts with RA? Yes....some. RA BEAM with 4mg Bari >Adalimumab for pain, HAQ, am stiffness but = on fatigue. POS0649 @RheumNow @eular_org #EULAR2021

Sounds fishy! Krill oil in #osteoarthritis is not a good catch! Fully neg RCT POS0276 @eular_org @RheumNow #EULAR2021 https://t.co/OGZbltDyxg

• https://twitter.com/kdao2011/status/1400834494609907717

How many of your postmenopausal RA ♀️ patients are on osteoporotic treatment? #EULAR2021 POS0164 ⭐️28% had prior fragility FX ⭐️50.5% at very high or high risk of fx according to FRAX 10 yr major fx risk Over 1/2 of patients at risk & indicated for treatment! @RheumNow

Who responds better to bDMARDs in RA, PsA & SpA? Men, women or equal? POS0208 #EULAR2021 @RheumNow @eular_org

2021 GRAPPA STRONG recs (cont'd): *⃣Crohn's Dz & UC: TNFi (not ETN), IL12/23i 🚫strong rec against IL17i 2021 GRAPPA CONDITIONAL recs for: *⃣ Uveitis: TNFi (not ETN), CyA *⃣ Crohn's Dz & UC: IL23i, JAKi, MTX OP0229 #EULAR2021 @RheumNow https://t.co/AWyKqSapWG

Lots of discussion about RA-ILD, but what about bronchiectasis (BR) in RA? We found a pooled prevalence of RA-BR of 18.7% (some may have been subclinical). POS0522 Prevalence of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis #EULAR2021 @Janetbirdope